The topics in this session will build on the “Value Workshop” to address the process of payment with respect to generating revenue specific to the US market. Speakers: Tonya Dowd,...

Read More →

Getting a product into U.S. hospitals goes beyond FDA approval. This session unpacks how Value Analysis Committees (VACs) work, what matters in their decision-making, and how non-U.S. medtech startups can effectively navigate hospital adoption and internal reimbursement pathways.

Breaking into U.S. hospital systems means understanding how Group Purchasing Organizations (GPOs) and Integrated Delivery Networks (IDNs) influence purchasing decisions. This session explains how these entities operate, what suppliers need to know, and how non-U.S. medtech companies can align with their processes to gain traction. Speakers: Suzy Engwall, HealthTech Strategies